GLP-1 Supply Update: What You Need to Know

If you’ve been using compounded Semaglutide injections for weight loss, there has been an important change that may affect your care. As of May 22, 2025, compounding pharmacies in the U.S. are no longer permitted to produce compounded Semaglutide injections due to updated guidance from the U.S. Food and Drug Administration (FDA).

Below is a breakdown of what’s changed—and what you can do now to stay on track with your treatment plan.

Why Did This Happen?

Compounding pharmacies are only allowed to create custom versions of medications when the brand-name version is in short supply. This previously included GLP-1 medications like Ozempic® and Wegovy®, which contain Semaglutide.

Now that the FDA has removed Semaglutide from the national shortage list, all U.S. compounding pharmacies were required to stop producing compounded Semaglutide injections as of May 22, 2025.

Why This Matters

To date, compounded Semaglutide injections have offered a more accessible and affordable option for many individuals—especially those whose insurance didn’t cover brand-name GLP-1s. It has helped thousands of people access safe, medically guided weight loss care during a time of high demand and limited supply.

With compounded injectable Semaglutide no longer available, you may need to adjust your treatment plan to avoid a gap in care.

What You Can Do Now

Alan Health offers seamless support to help you confidently transition to another weight loss treatment. Available alternatives include:

• FDA-approved GLP-1 medications (Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Generic Liraglutide)
• Oral compounded GLP-1s
• Compounded injectable GLP-1 Liraglutide
• Non-GLP-1 options, including Bupropion/Naltrexone/B12 Complex and Metformin

🔍 Explore all available weight loss options here

If you're unsure what this means for your care, your Alan Health provider or support team is here to help guide the transition. Our providers are here to help you find the right fit for your goals and budget.

Alan Health also offers supplement support and expert guidance to help you feel your best—no matter which treatment path you take.

Where Your Medication Comes From

Alan Health works with trusted, regulated 503A and 503B pharmacies, including Olympia and BPI, to ensure your medications are safe and high quality. These pharmacies follow strict guidelines and undergo regular inspections to maintain sterile environments and consistent standards. Your compounded prescriptions are made in facilities held to the highest level of oversight and care.

Frequently Asked Questions

• Why are compounded Semaglutide injections being discontinued?‍
  • The FDA has determined that compounded versions are no longer permitted now that there is adequate commercial supply.

• ‍Can I still order compounded Semaglutide?‍
  • At this time, we are only supporting existing Alan Health members on Semaglutide plans with continuity of care and transition plans. For alternative options, existing customers can explore directly in their Alan portal, and new customers can review here.

• ‍What are my options now?‍
  
  • Our providers are always available to discuss your treatment plan, inclduing switching to a highly-effective alternative weight loss program. Your options may include:
    
    • Brand-name GLP-1 treatment(Ozempic®, Wegovy®, Mounjaro®, Zepbound®, Generic Liraglutide)
    • Oral compounded GLP-1s
    • Compounded injectable Liraglutide
    • Non-GLP-1 treatments like Bupropion / Naltrexone / B12 and Metformin
  • ‍‍View all options here

• ‍What are my next steps if I can’t get compounded Semaglutide injections?‍
  • Talk to your Alan provider about switching to a brand-name option or other medically appropriate alternatives via your portal.

We’re Here to Help‍

If you have questions about your treatment plan or want to explore next steps, contact us at help@alanmeds.com or message your provider directly via your portal.

We’re here to support your weight loss journey—every step of the way.

‍